Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 19 Nov 2026, 19:34 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.3
- Combined market value
- ZAR 156.28T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IlluminaILMN · Health Care | 7.0 | ZAR 533.3B | ZAR 3,527.36 | 3.89% down | 76% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.0 | ZAR 310.9B | ZAR 11,115.96 | 1.67% down | 10% up | ||
| 103 | Gilead SciencesGILD · Health Care | 7.0 | ZAR 3.62T | ZAR 2,920.41 | 1.11% down | 35% up | ||
| 104 | Agilent TechnologiesA · Health Care | 7.2 | ZAR 869.7B | ZAR 3,084.51 | 0.47% down | 22% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | ZAR 107.5B | ZAR 760.29 | 0.92% up | 13% up | ||
| 106 | Halozyme TherapeuticsHALO · Health Care | 7.5 | ZAR 184B | ZAR 1,613.82 | 3.61% down | 39% up | ||
| 107 | United TherapeuticsUTHR · Health Care | 7.6 | ZAR 420.1B | ZAR 9,863.72 | 2.24% down | 22% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | ZAR 8.76T | ZAR 4,953.14 | 0.90% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | ZAR 593.1B | ZAR 29,817.99 | 1.79% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | ZAR 553.1B | ZAR 896.96 | 0.70% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.6 | ZAR 801.4B | ZAR 7,016.18 | 0.53% down | 16% up | ||
| 112 | West Pharmaceutical ServicesWST · Health Care | 9.0 | ZAR 481.3B | ZAR 6,909.31 | 2.14% down | 57% up | ||
| 113 | PenumbraPEN · Health Care | 9.0 | ZAR 220.2B | ZAR 5,587.43 | 0.27% down | 15% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.4 | ZAR 124.9B | ZAR 1,141.27 | 3.67% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | ZAR 199.6B | ZAR 1,270.68 | 0.05% down | 24% up | ||
| 116 | Travere TherapeuticsTVTX · Health Care | 9.5 | ZAR 81.5B | ZAR 848.55 | 3.35% down | 45% up | ||
| 117 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | ZAR 161B | ZAR 6,932.55 | 0.35% down | 27% down | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.8 | ZAR 1.04T | ZAR 1,815.06 | 1.30% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.9 | ZAR 129.4B | ZAR 1,646.94 | 0.85% down | 129% up | ||
| 120 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | ZAR 2.31T | ZAR 9,118.80 | 2.73% down | 27% up | ||
| 121 | Axsome TherapeuticsAXSM · Health Care | 11.2 | ZAR 124.5B | ZAR 2,367.30 | 1.09% up | 6% down | ||
| 122 | 10x GenomicsTXG · Health Care | 11.9 | ZAR 133.2B | ZAR 1,012.38 | 1.51% up | 247% up | ||
| 123 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | ZAR 109.4B | ZAR 1,675.51 | 3.66% up | 34% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.7 | ZAR 952.3B | ZAR 12,087.62 | 0.97% down | 1% up | ||
| 125 | Intuitive SurgicalISRG · Health Care | 14.1 | ZAR 2.47T | ZAR 7,131.43 | 3.06% down | 24% down | ||
| 126 | argenxARGX · Health Care | 14.3 | ZAR 1.04T | ZAR 16,460.29 | 0.07% up | 2% up | ||
| 127 | BillionToOneBLLN · Health Care | 14.3 | ZAR 76.2B | ZAR 1,594.86 | 0.31% down | 4% down | ||
| 128 | RepligenRGEN · Health Care | 14.8 | ZAR 191B | ZAR 2,987.17 | 1.01% down | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 16.0 | ZAR 172.4B | ZAR 1,140.48 | 1.30% down | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | ZAR 682.6B | ZAR 1,187.14 | 1.08% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.7 | ZAR 81B | ZAR 500.69 | 0.67% up | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.4 | ZAR 739.9B | ZAR 5,102.64 | 0.86% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.5 | ZAR 21.11T | ZAR 23,702.09 | 1.92% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.4 | ZAR 350.6B | ZAR 2,591.34 | 2.16% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 20.5 | ZAR 135.1B | ZAR 1,981.78 | 2.54% down | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.1 | ZAR 295.2B | ZAR 4,500.94 | 4.73% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 21.6 | ZAR 101.3B | ZAR 5,062.27 | 3.03% down | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.6 | ZAR 69.6B | ZAR 791.49 | 1.31% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.0 | ZAR 163.4B | ZAR 5,514.38 | 0.06% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.6 | ZAR 244.9B | ZAR 4,137.18 | 1.57% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.6 | ZAR 1.58T | ZAR 8,057.31 | 1.08% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.4 | ZAR 266.6B | ZAR 1,368.55 | 0.38% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.3 | ZAR 83.1B | ZAR 1,847.21 | 3.53% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.7 | ZAR 1.42T | ZAR 3,505.16 | 1.92% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.8 | ZAR 141.8B | ZAR 2,045.22 | 1.69% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 52.3 | ZAR 554B | ZAR 2,525.11 | 20.61% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.4 | ZAR 121.6B | ZAR 114.29 | 2.39% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.8 | ZAR 125.8B | ZAR 903.25 | 0.71% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 178 | ZAR 142.8B | ZAR 2,187.12 | 1.58% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 264 | ZAR 180.8B | ZAR 2,117.74 | 0.04% up | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1078 | ZAR 66.1B | ZAR 681.65 | 2.95% down | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1798 | ZAR 126.9B | ZAR 1,420.97 | 1.64% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2372 | ZAR 84.4B | ZAR 1,498.92 | 2.13% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3434 | ZAR 495.7B | ZAR 684.10 | 1.07% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4760 ZAR). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 19 Nov 2026, 19:34 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of ZAR 156.28T as of 19 Nov 2026, 19:34 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.